{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1032.55","meta":{"versionId":"21","lastUpdated":"2021-07-30T01:05:34.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"MITRE Author"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-keyWord","valueString":"CDS"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-07-30"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.55","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1032.55"}],"version":"20210730","name":"RiskAssessmentsRelevantToPainManagement","title":"Risk assessments relevant to pain management","status":"active","experimental":false,"date":"2021-07-30T01:05:34-04:00","publisher":"MITRE Steward","description":"NOTE: The codes in this value set do not represent all possible screening assessments. Please use with caution, as additional codes may be relevant to supporting this objective.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Risk screening tools and assessments that can identify risks for opioid therapy.),(Data Element Scope: Screening tools that assess the risk of  substance abuse, drug or alcohol use, depression, anxiety. NOTE: The codes in this value set do not represent all possible screening assessments. Please use with caution, as additional codes may be relevant to supporting this objective.),(Inclusion Criteria: Select screening and assessment tools used to assess the risk of substance abuse, drug or alcohol use, depression, anxiety. NOTE: This value set may not include every possible assessment that might be useful to screen for opioid therapy risks.),(Exclusion Criteria: None, however this list may not be comprehensive. Please use with caution, as additional codes may be relevant to supporting this objective. In addition, some evidence-based risk assessments did not have an associated LOINC code at the time that this value set was published.)","compose":{"include":[{"system":"http://loinc.org","concept":[{"code":"44261-6","display":"Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"},{"code":"55758-7","display":"Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"},{"code":"70274-6","display":"Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]"},{"code":"75624-7","display":"Total score [AUDIT]"},{"code":"75626-2","display":"Total score [AUDIT-C]"},{"code":"82667-7","display":"Total score [DAST-10]"},{"code":"91392-1","display":"Total score ORT"},{"code":"91393-9","display":"Opioid risk tool panel"}]}]},"expansion":{"identifier":"urn:uuid:e67a63ef-0ea5-43d1-852d-79f6bcf8e5c6","timestamp":"2023-12-10T20:42:53-05:00","total":8,"contains":[{"system":"http://loinc.org","version":"2.76","code":"44261-6","display":"Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"},{"system":"http://loinc.org","version":"2.76","code":"55758-7","display":"Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"},{"system":"http://loinc.org","version":"2.76","code":"70274-6","display":"Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]"},{"system":"http://loinc.org","version":"2.76","code":"75624-7","display":"Total score [AUDIT]"},{"system":"http://loinc.org","version":"2.76","code":"75626-2","display":"Total score [AUDIT-C]"},{"system":"http://loinc.org","version":"2.76","code":"82667-7","display":"Total score [DAST-10]"},{"system":"http://loinc.org","version":"2.76","code":"91392-1","display":"Total score ORT"},{"system":"http://loinc.org","version":"2.76","code":"91393-9","display":"Opioid risk tool panel"}]}}